Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Modeling And Simulation
MedTech
Certara models aid 19 approvals as FDA pursues in silico tools
Certara said its software supported 95% of the 20 novel FDA approvals from the first half of this year, as the agency aims to modernize its reviews.
Conor Hale
Aug 6, 2018 12:05pm
Certara breaks into real-world value services with Analytica Laser buy
Apr 18, 2018 8:01am
Medtronic gets U.S., EU nods for GPS-style surgical device
Sep 13, 2017 9:35am
EQT to buy Certara from Arsenal for $850M
Jul 11, 2017 9:57am
Nostrum sets up shop with ambition to use supercomputers to speed drug discovery
Jul 15, 2016 7:14am
Bionext snags Rhenovia team, tech to predict cell signaling
Jul 7, 2016 11:38am
